Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04552223
Title Nivolumab Plus Relatlimab in Patients With Metastatic Uveal Melanoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jose Lutzky, MD

uveal melanoma


Nivolumab + Relatlimab

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.